These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37142338)

  • 1. Single-nucleus chromatin accessibility identifies a critical role for TWIST1 in idiopathic pulmonary fibrosis myofibroblast activity.
    Valenzi E; Bahudhanapati H; Tan J; Tabib T; Sullivan DI; Nouraie M; Sembrat J; Fan L; Chen K; Liu S; Rojas M; Lafargue A; Felsher DW; Tran PT; Kass DJ; Lafyatis R
    Eur Respir J; 2023 Jul; 62(1):. PubMed ID: 37142338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic and Epigenetic Profiling of Fibroblasts in Idiopathic Pulmonary Fibrosis.
    Hanmandlu A; Zhu L; Mertens TCJ; Collum S; Bi W; Xiong F; Wang R; Amirthalingam RT; Ren D; Han L; Jyothula SSSK; Li W; Zheng WJ; Karmouty-Quintana H
    Am J Respir Cell Mol Biol; 2022 Jan; 66(1):53-63. PubMed ID: 34370624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Twist1 in the Mesenchymal Compartment Promotes Increased Fibrosis in Experimental Lung Injury by Enhanced Expression of CXCL12.
    Tan J; Tedrow JR; Nouraie M; Dutta JA; Miller DT; Li X; Yu S; Chu Y; Juan-Guardela B; Kaminski N; Ramani K; Biswas PS; Zhang Y; Kass DJ
    J Immunol; 2017 Mar; 198(6):2269-2285. PubMed ID: 28179498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATF3 -activated accelerating effect of LINC00941/lncIAPF on fibroblast-to-myofibroblast differentiation by blocking autophagy depending on ELAVL1/HuR in pulmonary fibrosis.
    Zhang J; Wang H; Chen H; Li H; Xu P; Liu B; Zhang Q; Lv C; Song X
    Autophagy; 2022 Nov; 18(11):2636-2655. PubMed ID: 35427207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YAP1/Twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF.
    Chen Y; Zhao X; Sun J; Su W; Zhang L; Li Y; Liu Y; Zhang L; Lu Y; Shan H; Liang H
    Cell Death Differ; 2019 Sep; 26(9):1832-1844. PubMed ID: 30644438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways.
    Tumelty KE; Smith BD; Nugent MA; Layne MD
    J Biol Chem; 2014 Jan; 289(5):2526-36. PubMed ID: 24344132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis.
    Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP
    Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production.
    Al-Habeeb F; Aloufi N; Traboulsi H; Liu X; Nair P; Haston C; Azuelos I; Huang SK; White ES; Gallouzi IE; Di Marco S; Eidelman DH; Baglole CJ
    J Cell Physiol; 2021 Oct; 236(10):6836-6851. PubMed ID: 33855709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of RUNX1 blocks the differentiation of lung fibroblasts to myofibroblasts.
    Dubey S; Dubey PK; Umeshappa CS; Ghebre YT; Krishnamurthy P
    J Cell Physiol; 2022 Apr; 237(4):2169-2182. PubMed ID: 35048404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis.
    Xiao X; Senavirathna LK; Gou X; Huang C; Liang Y; Liu L
    Physiol Rep; 2016 Sep; 4(17):. PubMed ID: 27582065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA GAS5 suppresses TGF-β1-induced transformation of pulmonary pericytes into myofibroblasts by recruiting KDM5B and promoting H3K4me2/3 demethylation of the PDGFRα/β promoter.
    Wang Y; Chen D; Xie H; Zhou S; Jia M; He X; Guo F; Lai Y; Tang XX
    Mol Med; 2023 Mar; 29(1):32. PubMed ID: 36918759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis.
    Bamberg A; Redente EF; Groshong SD; Tuder RM; Cool CD; Keith RC; Edelman BL; Black BP; Cosgrove GP; Wynes MW; Curran-Everett D; De Langhe S; Ortiz LA; Thorburn A; Riches DWH
    Am J Respir Crit Care Med; 2018 Oct; 198(7):914-927. PubMed ID: 29727583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
    Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
    Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central lung gene expression associates with myofibroblast features in idiopathic pulmonary fibrosis.
    Huang Y; Guzy R; Ma SF; Bonham CA; Jou J; Schulte JJ; Kim JS; Barros AJ; Espindola MS; Husain AN; Hogaboam CM; Sperling AI; Noth I
    BMJ Open Respir Res; 2023 Feb; 10(1):. PubMed ID: 36725082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The small heat-shock protein αB-crystallin is essential for the nuclear localization of Smad4: impact on pulmonary fibrosis.
    Bellaye PS; Wettstein G; Burgy O; Besnard V; Joannes A; Colas J; Causse S; Marchal-Somme J; Fabre A; Crestani B; Kolb M; Gauldie J; Camus P; Garrido C; Bonniaud P
    J Pathol; 2014 Mar; 232(4):458-72. PubMed ID: 24307592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highlighting fibroblast plasticity in lung fibrosis: the WI-38 cell line as a model for investigating the myofibroblast and lipofibroblast switch.
    Vásquez-Pacheco E; Marega M; Lingampally A; Fassy J; Truchi M; Goth K; Trygub L; Taghizadeh S; Bartkuhn M; Alexopoulos I; Dong Y; Lebrigand K; Gunther A; Chen C; Zhang J; Chao CM; Al Alam D; El Agha E; Mari B; Bellusci S; Rivetti S
    Theranostics; 2024; 14(9):3603-3622. PubMed ID: 38948058
    [No Abstract]   [Full Text] [Related]  

  • 18. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scleraxis regulates Twist1 and Snai1 expression in the epithelial-to-mesenchymal transition.
    Al-Hattab DS; Safi HA; Nagalingam RS; Bagchi RA; Stecy MT; Czubryt MP
    Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H658-H668. PubMed ID: 29906225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.
    Enomoto Y; Matsushima S; Shibata K; Aoshima Y; Yagi H; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
    Clin Sci (Lond); 2018 Jul; 132(14):1565-1580. PubMed ID: 30006483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.